Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jane Wimpfheimer Newburger, M.D.

Co-Author

This page shows the publications co-authored by Jane Newburger and Mary Son.
Connection Strength

7.107
  1. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319.
    View in: PubMed
    Score: 0.849
  2. Kawasaki Disease. Pediatr Rev. 2018 Feb; 39(2):78-90.
    View in: PubMed
    Score: 0.774
  3. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores. J Am Heart Assoc. 2017 May 31; 6(6).
    View in: PubMed
    Score: 0.739
  4. Kawasaki disease. Pediatr Rev. 2013 Apr; 34(4):151-62.
    View in: PubMed
    Score: 0.554
  5. Management of Kawasaki disease: corticosteroids revisited. Lancet. 2012 Apr 28; 379(9826):1571-2.
    View in: PubMed
    Score: 0.514
  6. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr. 2011 Apr; 158(4):644-649.e1.
    View in: PubMed
    Score: 0.471
  7. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009 Jul; 124(1):1-8.
    View in: PubMed
    Score: 0.427
  8. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives: Design and Rationale of the MUSIC Study. Am Heart J. 2021 Aug 18.
    View in: PubMed
    Score: 0.247
  9. Therapy for Multisystem Inflammatory Syndrome in Children. Reply. N Engl J Med. 2021 Sep 23; 385(13):e42.
    View in: PubMed
    Score: 0.247
  10. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. N Engl J Med. 2021 07 01; 385(1):23-34.
    View in: PubMed
    Score: 0.245
  11. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. Pediatr Rheumatol Online J. 2021 Mar 17; 19(1):31.
    View in: PubMed
    Score: 0.240
  12. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3.
    View in: PubMed
    Score: 0.237
  13. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950.
    View in: PubMed
    Score: 0.234
  14. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252.
    View in: PubMed
    Score: 0.232
  15. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. J Pediatr. 2019 09; 212:87-92.
    View in: PubMed
    Score: 0.213
  16. Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. Pediatr Blood Cancer. 2021 Sep 17; e29355.
    View in: PubMed
    Score: 0.062
  17. Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents. EClinicalMedicine. 2021 Oct; 40:101112.
    View in: PubMed
    Score: 0.062
  18. Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis. BMC Rheumatol. 2021 Aug 12; 5(1):27.
    View in: PubMed
    Score: 0.062
  19. Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study. Arch Dis Child. 2021 Jul 08.
    View in: PubMed
    Score: 0.061
  20. Mistaken MIS-C: A Case Series of Bacterial Enteritis Mimicking MIS-C. Pediatr Infect Dis J. 2021 04 01; 40(4):e159-e161.
    View in: PubMed
    Score: 0.060
  21. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021 03 16; 325(11):1074-1087.
    View in: PubMed
    Score: 0.060
  22. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. CJC Open. 2021 Jul; 3(7):880-887.
    View in: PubMed
    Score: 0.060
  23. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. Pediatrics. 2021 05; 147(5).
    View in: PubMed
    Score: 0.060
  24. High-Throughput Screening of Kawasaki Disease Sera for Antiviral Antibodies. J Infect Dis. 2020 11 09; 222(11):1853-1857.
    View in: PubMed
    Score: 0.059
  25. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.058
  26. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021 Feb; 180(2):307-322.
    View in: PubMed
    Score: 0.058
  27. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020 07 23; 383(4):334-346.
    View in: PubMed
    Score: 0.057
  28. Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses. Arch Dis Child. 2020 08; 105(8):772-777.
    View in: PubMed
    Score: 0.056
  29. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2020 02; 79(2):225-231.
    View in: PubMed
    Score: 0.055
  30. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 06; 143(6).
    View in: PubMed
    Score: 0.053
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.